Articles by The Wall Street Analyzer

About The Wall Street Analyzer
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
News Feed

Zomedica CEO Interview with Wall Street Analyzer Discusses First Quarter 2022 Earnings and Future Plans

May 17, 2022 The Wall Street Analyzer Comments Off on Zomedica CEO Interview with Wall Street Analyzer Discusses First Quarter 2022 Earnings and Future Plans

ANN ARBOR, MI / ACCESSWIRE / May 16, 2022 / Zomedica Corp. (NYSE American:ZOM) (“Zomedica” or “Company”), a veterinary health company offering point-of-care diagnostics and therapeutic products for companion animals, is pleased to announce the interview with […]

News Feed

High Sierra Technologies, Inc. Has Been Awarded United States Patent Number 11,338,222 And Has Also Filed Continuation-In-Part Application Number 17/098,539

May 11, 2022 The Wall Street Analyzer Comments Off on High Sierra Technologies, Inc. Has Been Awarded United States Patent Number 11,338,222 And Has Also Filed Continuation-In-Part Application Number 17/098,539

Reno, Nevada, May 11, 2022 (GLOBE NEWSWIRE) — High Sierra Technologies, Inc. (OTCQB: HSTI) (“HSTI”) today received an Issue Notification from the United States Patent and Trademark Office (the “USPTO”) stating that, on May 24, […]